Bridget Nolan

Bridget Nolan

Auto-generated profile, based on publicly available information

Bridget Nolan

New York Medical College, 15 Dana Road, Valhalla, NY, 10595, USA; Department of Neurosurgery, Westchester Medical Center, 100 Woods Road, Valhalla, NY 10595, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2023 in Brain Circulation
Verified
Journal Article
Open access
ALAiden K. Lui
Aiden K. Lui
FLFangyi Lin
Fangyi Lin
AUAnaz Uddin
Anaz Uddin
BNBridget Nolan
Bridget Nolan
KCKevin Clare
Kevin Clare
FAFawaz Al-Mufti
Fawaz Al-Mufti
BACKGROUND: Intracerebral hemorrhage (ICH) carries significant morbidity and mortality. Previous single-center retrospective analysis suggests that end-stage renal disease (ESRD) is a risk factor for severe ICH and worse outcomes. This investigation aims to examine the impact of ESRD on ICH severity, complications, and outcomes using a multicenter national database. METHODS: The International Classification of Disease, Ninth and Tenth Revision Clinical Modification codes were used to query the National Inpatient Sample for patients with ICH and ESRD between 2010 and 2019. Primary endpoints were the functional outcome, length of stay (LOS), and in-hospital mortality. Multivariate variable regression models and a propensity-score matched analysis were established to analyze patient outcomes associated with baseline patient characteristics. RESULTS: We identified 211,266 patients with ICH, and among them, 7,864 (3.77%) patients had a concurrent diagnosis of ESRD. Patients with ESRD were younger (60.85 vs. 67.64, P < 0.01) and demonstrated increased ICH severity (0.78 vs. 0.77, P < 0.01). ESRD patients experienced higher rates of sepsis (15.9% vs. 6.15%, P < 0.01), acute myocardial infarction (8.05% vs. 3.65%, P < 0.01), and cardiac arrest (5.94% vs. 2.4%, P < 0.01). In addition, ESRD predicted poor discharge disposition (odds ratio [OR]: 2.385, 95% confidence interval [CI]: 2.227–2.555, P < 0.01), longer hospital LOS (OR: 1.629, 95% CI: 1.553–1.709, P < 0.01), and in-hospital mortality (OR: 2.786, 95% CI: 2.647–2.932, P < 0.01). CONCLUSIONS: This study utilizes a multicenter database to analyze the effect of ESRD on ICH outcomes. ESRD is a significant predictor of poor functional outcomes, in-hospital mortality, and prolonged stay in the ICH population.

1 September 2024 in Epilepsy & Behavior
Verified
Journal Article
Open access
CBCameron P. Beaudreault
Cameron P. Beaudreault
SCSharon Chiang
Sharon Chiang
ASAriel Sacknovitz
Ariel Sacknovitz
RMRobert Moss
Robert Moss
PBPaige Brabant
Paige Brabant
SWSteven Wolf
Steven Wolf
To assess the impact of vagus nerve stimulation (VNS) on quality of life contributors such as rescue medications. Using the seizure diary application SeizureTracker™ database, we examined trends in rescue administration frequency before and after the first recorded VNS magnet swipe in patients with drug-resistant epilepsy who had 1) At least one VNS magnet swipe recorded in the diary, and 2) Recorded usage of a benzodiazepine rescue medication (RM) within 90 days prior to the first swipe. A paired Wilcoxon rank-sum test was used to assess changes in RM usage frequency between 30-, 60-, 90-, 180- and 360-day intervals beginning 30 days after first magnet swipe. Longitudinal changes in RM usage frequency were assessed with a generalized estimating equation model. We analyzed data of 95 patients who met the inclusion criteria. Median baseline seizure frequency was 8.3 seizures per month, with median baseline rescue medication usage frequency of 2.1 administrations per month (SD 3.3). Significant reductions in rescue medication usage were observed in the 91 to 180 day interval after first VNS magnet swipe, and at 181 to 360 days and at 361 to 720 days, with the magnitude of reduction increasing over time. Decreases in rescue medication usage were sustained when controlling for patients who did not record rescue medication use after the first VNS magnet swipe (N=91). Significant predictors of reductions in rescue medication included baseline frequency of rescue medication usage and time after first VNS magnet swipe. This retrospective analysis suggests that usage of rescue medications is reduced following the start of VNS treatment in patients with epilepsy, and that the magnitude of reduction may progressively increase over time.

2 July 2024 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
GSGaladu Subah
Galadu Subah
RPRohan N Patel
Rohan N Patel
BNBridget Nolan
Bridget Nolan
MFMichael Peter Fortunato
Michael Peter Fortunato
ALAiden Lui
Aiden Lui
FAFawaz Al-Mufti
Fawaz Al-Mufti

8 May 2023 in Interventional Neuroradiology
Verified
Journal Article
Closed access
NMNicholas W Mui
Nicholas W Mui
AUAnaz Uddin
Anaz Uddin
MFMichael Peter Fortunato
Michael Peter Fortunato
BNBridget E Nolan
Bridget E Nolan
KCKevin Clare
Kevin Clare
FAFawaz Al-Mufti
Fawaz Al-Mufti
Objectives: Chronic inflammation of the gastrointestinal tract is a hallmark of inflammatory bowel disease (IBD). This increased inflammation is thought to induce a hypercoagulable state that increases the risk for stroke. However, few studies have examined the association between IBD and acute ischemic stroke (AIS). Thus, this study aims to investigate the incidence, treatments, complications, and outcomes of AIS in patients with IBD. Materials & Methods: ICD-9-CM and ICD-10-CM codes were used to query the National Inpatient Sample for AIS and IBD diagnosis. Baseline demographics, clinical characteristics, complications, treatments, and outcomes were assessed through descriptive statistics, multivariate regression, and propensity score matching (PSM) analysis. Acute stroke severity was assessed using the National Institute of Heath's Stroke Severity Score (SSS) as a template. Results: 1,609,817 patients were diagnosed with AIS between 2010 through 2019. 7468 (0.46%) had concomitant diagnoses of IBD. AIS patients with IBS were younger, more likely to be white and female, but less likely to be obese. Although IBD patients had comparable stroke severities (p = 0.64) to their non-IBS counterparts, they received stroke intervention at statistically different rates than their non-IBD counterparts. Additionally, IBD patients had higher rates of in-hospital complications (p < 0.01) and longer lengths of stay (LOS) (p < 0.01). Conclusions: IBD patients develop AIS at a younger age with similar rates of stroke severity to their non-IBD counterparts, but receive higher rates of tissue plasminogen activator administration and decreased rates of mechanical thrombectomy. Our research shows that patients with IBD are at risk for AIS at an earlier age and are more likely to have complications. This underlies a connection between IBD and a hypercoagulable state that could predispose patients to AIS.

8 May 2023 in Interventional Neuroradiology
Verified
Journal Article
Closed access
EFEric Feldstein
Eric Feldstein
AZAllison Zhong
Allison Zhong
KCKevin Clare
Kevin Clare
BNBridget Nolan
Bridget Nolan
SPSmit Patel
Smit Patel
FAFawaz Al-Mufti
Fawaz Al-Mufti
Background: Limited literature exists on the morbidity and mortality of AVM associated intracerebral hemorrhage (ICH) compared with non-AVM ICH. Objective: We examine morbidity and mortality in cAVM in a large nationwide inpatient sample to create a prognostic inpatient ruptured AVM mortality score. Methods: This retrospective cohort study from 2008 to 2014 compares outcomes in cAVM related hemorrhages and ICH utilizing the National Inpatient Sample database. Diagnostic codes for ICH and AVM underlying ICH were identified. We compared case fatality according to medical complications. Multivariate analysis was used to derive hazard ratios and 95% confidence intervals to assess odds of mortality. Results: We identified 6496 patients with ruptured AVMs comparing them to 627,185 admitted with ICH. Mortality was lower for ruptured AVMs (11%) compared to ICH (22%) [ p < 0.01]. Mortality associated factors were liver disease (OR 2.64, CI 1.81–3.85, p < .001), diabetes mellitus (OR 2.42, CI 1.38–4.22, p = 0.002), alcohol abuse (OR 1.81, CI 1.31–2.49, p = 0.001), hydrocephalus (OR 3.35 CI 2.81–4.00, p < 0.001), cerebral edema (OR 1.5, 1.25–1.85, p < 0.001), cardiac arrest (OR 15, CI 7.9–30, p < 0.001), and pneumonia (OR 1.93, CI 1.51–2.47, p < 0.001). A 0–5 ruptured AVM mortality score was developed: Cardiac arrest (=3), age >60 (=1), Black race (=1), chronic liver failure (=1) diabetes mellitus (=1), pneumonia (=1), alcohol abuse (=1) and cerebral edema (=1). Mortality increased with score. No patient with 5 or more points survived. Conclusion: The Ruptured AVM Mortality Score allows for risk stratification on patients with ICH due to ruptured AVM. This scale could prove useful in prognostication and patient education.

22 August 2024 in Life
Verified
Journal Article
Open access
PDF file
SVSima Vazquez
Sima Vazquez
AJAarti Kishore Jain
Aarti Kishore Jain
BNBridget Nolan
Bridget Nolan
ESEris Spirollari
Eris Spirollari
KCKevin Clare
Kevin Clare
FAFawaz Al-Mufti
Fawaz Al-Mufti
As the incidence of subdural hematoma is increasing, it is important to understand symptomatology and clinical variables associated with treatment outcomes and mortality in this population; patients with subdural hematoma were selected from the National Inpatient Sample (NIS) Database between 2016 and 2020 using International Classification of Disease 10th Edition (ICD10) codes. Moderate-to-severe subdural hematoma patients were identified using the Glasgow Coma Scale (GCS). Multivariate regression was first used to identify predictors of in-hospital mortality and then beta coefficients were used to create a weighted mortality score. Of 29,915 patients admitted with moderate-to-severe subdural hematomas, 12,135 (40.6%) died within the same hospital admission. In a multivariate model of relevant demographic and clinical covariates, age greater than 70, diabetes mellitus, mechanical ventilation, hydrocephalus, and herniation were independent predictors of mortality (p < 0.001 for all). Age greater than 70, diabetes mellitus, mechanical ventilation, hydrocephalus, and herniation were assigned a “1” in a weighted mortality score. The ROC curve for our model showed an area under the curve of 0.64. Age greater than 70, diabetes mellitus, mechanical ventilation, hydrocephalus, and herniation were predictive of mortality. We created the first clinically relevant weighted mortality score that can be used to stratify risk, guide prognosis, and inform family discussions.